Privia Health Group, Inc. (NASDAQ:PRVA) Shares Sold by OneDigital Investment Advisors LLC

OneDigital Investment Advisors LLC lowered its position in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 15.2% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 378,431 shares of the company's stock after selling 67,884 shares during the quarter. OneDigital Investment Advisors LLC owned approximately 0.31% of Privia Health Group worth $8,496,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in the company. EverSource Wealth Advisors LLC lifted its position in shares of Privia Health Group by 7,833.3% during the 4th quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company's stock worth $47,000 after buying an additional 2,350 shares during the last quarter. Bessemer Group Inc. lifted its position in shares of Privia Health Group by 2,393.4% during the 1st quarter. Bessemer Group Inc. now owns 2,269 shares of the company's stock worth $51,000 after buying an additional 2,178 shares during the last quarter. GAMMA Investing LLC lifted its position in shares of Privia Health Group by 113.1% during the 1st quarter. GAMMA Investing LLC now owns 2,866 shares of the company's stock worth $64,000 after buying an additional 1,521 shares during the last quarter. Financial Management Professionals Inc. lifted its position in shares of Privia Health Group by 28.7% during the 1st quarter. Financial Management Professionals Inc. now owns 3,383 shares of the company's stock worth $76,000 after buying an additional 754 shares during the last quarter. Finally, Quadrant Capital Group LLC lifted its position in shares of Privia Health Group by 11.8% during the 4th quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company's stock worth $95,000 after buying an additional 511 shares during the last quarter. Hedge funds and other institutional investors own 94.48% of the company's stock.

Privia Health Group Trading Up 0.9%

PRVA stock traded up $0.19 on Friday, hitting $22.11. The company's stock had a trading volume of 397,782 shares, compared to its average volume of 763,373. The stock has a market cap of $2.70 billion, a price-to-earnings ratio of 184.27, a price-to-earnings-growth ratio of 3.54 and a beta of 0.82. The firm has a 50 day moving average of $23.08 and a two-hundred day moving average of $22.92. Privia Health Group, Inc. has a 1 year low of $16.47 and a 1 year high of $26.09.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on PRVA. Truist Financial boosted their price objective on shares of Privia Health Group from $27.00 to $28.00 and gave the stock a "buy" rating in a research report on Thursday, April 10th. Robert W. Baird boosted their price objective on shares of Privia Health Group from $24.00 to $26.00 and gave the stock an "outperform" rating in a research report on Tuesday, April 15th. JPMorgan Chase & Co. boosted their price objective on shares of Privia Health Group from $29.00 to $32.00 and gave the stock an "overweight" rating in a research report on Wednesday, May 28th. JMP Securities reiterated a "market outperform" rating and issued a $29.00 price target on shares of Privia Health Group in a research report on Monday, April 28th. Finally, Barclays upped their price target on shares of Privia Health Group from $23.00 to $24.00 and gave the company an "equal weight" rating in a research report on Tuesday, May 27th. One research analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, Privia Health Group currently has a consensus rating of "Buy" and a consensus target price of $27.77.

Insider Buying and Selling at Privia Health Group

In other Privia Health Group news, CFO David Mountcastle sold 3,445 shares of the business's stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $23.33, for a total value of $80,371.85. Following the transaction, the chief financial officer directly owned 176,231 shares of the company's stock, valued at approximately $4,111,469.23. The trade was a 1.92% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Matthew Shawn Morris sold 10,309 shares of the business's stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $23.33, for a total transaction of $240,508.97. Following the completion of the transaction, the director directly owned 59,792 shares in the company, valued at $1,394,947.36. This represents a 14.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 45,949 shares of company stock valued at $1,100,368. 10.70% of the stock is owned by company insiders.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.